Shares of Firefly Neuroscience, Inc. (AIFF) are surging roughly 43 percent on Friday morning trading following the announcement of discovery of new brain wave biomarkers for differential diagnosis of ADHD.
The company's shares are currently trading at $2.50 on the Nasdaq, up 43.97 percent. The stock opened at $1.9 and has climbed as high as $2.64 so far in today's session. Over the past year, it has traded in a range of $0.62 to $6.00.
With the company's AI-powered EEG/ERP technology, health experts could identify which ADHD subtype a patient has, which would help them to determine the most appropriate treatment type, inform dosage decisions, and potentially monitor whether an intervention is working.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.